Results 81 to 90 of about 14,564 (189)

Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity

Indian Journal of Ophthalmology, 2019
Purpose: To study the efficacy of intravitreal Aflibercept, an anti Vascular Endothelial Growth factor, (anti-VEGF) in Retinopathy of Prematurity (ROP).
Vasumathy Vedantham
doaj   +1 more source

Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration

, 2013
Michael Thomas,1 Shaymaa S Mousa,2 Shaker A Mousa1 1Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, NY, USA; 2The Johns Hopkins University, Baltimore, MD, USA Abstract: Wet age-related macular degeneration (AMD)
Thomas M, Mousa SS, Mousa SA
core  

Aflibercept: side effects in focus

, 2018
A new anti-angiogenic drug aflibercept has been authorized as a second-line therapy in patients with metastatic colon cancer. The use of this drug as part of FOLFIRI regimen significantly reduces the risk of disease progression (RR = 0.758, p = 0.00007).
M. Yu. Fedyanin
core   +1 more source

Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema : The INSIGHT Randomized Clinical Trial [PDF]

Biosimilars may be lower-cost alternatives to originator biologic products, potentially offering expanded access or reduced economic burden, but have not been evaluated with aflibercept in diabetic macular edema (DME).To compare efficacy and safety of ...
Patel Sunil S., Kishino Genichiro, Agarwal Somesh, Kollaborációs szervezet: INSIGHT Study Group, Loganathan Subramanian, Marcus Dennis M., Baumane Kristine, Dégi Rózsa, Beckmann Katrin, Oleksy Piotr, Bressler Susan B., Ernest Jan, Apte Rajendra S., Kamei Motohiro, Ganapathi Prasanna C., Barve Abhijit, Reichstein David A., et al., Gupta Vishali   +18 more
core   +1 more source

One-Month Real-World Comparison of Aflibercept 8 mg Versus 2 mg in Treatment-Naïve and Previously Treated Eyes with Neovascular Age-Related Macular Degeneration

Biologics
Background/Objectives: The relative efficacy of 8 mg aflibercept compared to 2 mg in treating neovascular age-related macular degeneration (nAMD) has not been fully established. This study aims to compare the visual and anatomical outcomes of aflibercept
Takahiro Mizukami, Satoru Ueno, Soichiro Mishima, Yoshikazu Shimomura   +3 more
doaj   +1 more source

Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes

Clinical Ophthalmology, 2021
Faye Horner, Peck Lin Lip, Bashar R Mohammed, William Fusi-Rubiano, Eesha Gokhale, Bushra Mushtaq, Randhir Chavan Birmingham & Midland Eye Centre, Birmingham, UKCorrespondence: Randhir ChavanBirmingham & Midland Eye Centre, Sandwell & West ...
Horner F, Lip PL, Mohammed BR, Fusi-Rubiano W, Gokhale E, Mushtaq B, Chavan R   +6 more
doaj  

Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration

, 2015
Arshad M Khanani Sierra Eye Associates, Reno, NV, USA Purpose: To evaluate the durability of fixed bimonthly dosing of intravitreal aflibercept for neovascular age-related macular degeneration.Methods: Records of 16 patients were retrospectively ...
Khanani AM
core  

Acceptable price per aflibercept injection.

, 2018
Which price is acceptable for one aflibercept injection depends on what society is willing to pay. The graph shows that at a willingness-to-pay of €80,000 per QALY aflibercept should cost no more than €533.
Maroeska M. Rovers (120760), Carel B. Hoyng (552359), Gert Jan van der Wilt (659529), Freekje van Asten (659525), Charlotte T. J. Michels (5233892), B. Jeroen Klevering (659530), Janneke P. C. Grutters (5233889)   +6 more
core   +1 more source

Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration

, 2015
Chandrakumar Balaratnasingam,1–3 Elona Dhrami-Gavazi,1,2,4 Jesse T McCann,1,2,4,5 Quraish Ghadiali,1,2 K Bailey Freund1,2,4,5 1Vitreous-Retina-Macula Consultants of New York, NY, USA; 2LuEsther T Mertz Retinal Research Center, Manhattan Eye, Ear ...
Freund KB, Balaratnasingam C, McCann JT, Ghadiali Q, Dhrami-Gavazi E   +4 more
core  

Influence of aflibercept on platelet activation profile

, 2018
\ua9 2018 Elsevier Ltd Aflibercept appears to accumulate in systemic circulation following intravitreal injections in therapy of neovascular age-related macular degeneration.
Sobolewska B, Schenke-Layland K, Golenko J, Ziemssen F, Grimmel C, Sopova K, Poeschel S, Stellos K, Biedermann T, Gatsiou A   +9 more
core   +1 more source